Pharma Industry

How India can rejig its science and healthcare research regime, and why the time to do it is now.

3 years ago


Synopsis

Despite considerable policy push, India has not been able to achieve a breakthrough as an academic powerhouse. This is an opportune time for the country to reboot a hybrid model of industry and university-based research. It will help if policymakers take a look at how countries like the US have been pulling it off.

There are several theories on the origin of the novel coronavirus. As the world awaits a vaccine with a bated breath, the pandemic has brought several home truths to the foreground — India’s chronic under-investment in medical infrastructure and the need for reforms in medical education to name a few.Despite being a tongue-twister, a relatively unknown drug, hydroxychloroquine, has entered the popular lexicon. But the fact remains that India,

BY

  • GIFT ARTICLE
  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise





Source link

You may also like

Subscribe Our Newsletter for regular updates!